CE Session: Bacteriophages: The Next Generation of Antimicrobial Agents

Description: 

This session is part of the Sepsis Alliance AMR Conference 2025.

 Bacteriophages, or phages, are emerging as a promising solution in the fight against antimicrobial resistance. This session explores the advancements and applications of bacteriophage therapy, offering a comprehensive overview of its current global landscape. Key topics include the dynamic interplay between bacteriophages, bacteria, and the human host, as well as an in-depth examination of research efforts and clinical trials aimed at bringing phage therapy into mainstream medical practice. Attendees will gain insight into the challenges and opportunities shaping the future of this next-generation antimicrobial agent.

Learning Objectives: 

At the end of the session, the learner should be able to:

•  Analyze the current landscape of bacteriophage (phage) therapy in the United States and globally;
• Evaluate the interactions between bacteriophages, bacteria, and the human host in the context of phage therapy;
• Assess the current research and clinical trial landscape for bacteriophage therapy, discussing potential pathways for mainstream adoption and clinical application 

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.